Neuropeptide signaling requires the presence of G protein-coupled receptors (GPCRs) at the cell surface. Activated GPCRs interact with ␤-arrestins, which mediate receptor desensitization, endocytosis, and mitogenic signaling, and the peptide-receptor-arrestin complex is sequestered into endosomes. Although dissociation of ␤-arrestins is required for receptor recycling and resensitization, the critical event that initiates this process is unknown. Here we report that the agonist availability in the endosomes, controlled by the membrane metalloendopeptidase endothelin-converting enzyme 1 (ECE-1), determines stability of the peptide-receptorarrestin complex and regulates receptor recycling and resensitization. Substance P (SP) binding to the tachykinin neurokinin 1 receptor (NK 1R) induced membrane translocation of ␤-arrestins followed by trafficking of the SP-NK1R-␤-arrestin complex to early endosomes containing ECE-1a-d. ECE-1 degraded SP in acidified endosomes, disrupting the complex; ␤-arrestins returned to the cytosol, and the NK1R, freed from ␤-arrestins, recycled and resensitized. An ECE-1 inhibitor, by preventing NK 1R recycling in endothelial cells, inhibited resensitization of SP-induced inflammation. This mechanism is a general one because ECE-1 similarly regulated NK 3R resensitization. Thus, peptide availability in endosomes, here regulated by ECE-1, determines the stability of the peptidereceptor-arrestin complex. This mechanism regulates receptor recycling, which is necessary for sustained signaling, and it may also control ␤-arrestin-dependent mitogenic signaling of endocytosed receptors. We propose that other endosomal enzymes and transporters may similarly control the availability of transmitters in endosomes to regulate trafficking and signaling of GPCRs. Antagonism of these endosomal processes represents a strategy for inhibiting sustained signaling of receptors, and defects may explain the tachyphylaxis of drugs that are receptor agonists.
T
he mechanisms controlling cellular sensitivity to agonists of G protein-coupled receptors (GPCRs) are crucially important because defects cause uncontrolled signaling and disease, and the molecules involved are therapeutic targets (1) . Cell surface peptidases and receptor desensitization terminate cellular responses to neuropeptides, such as substance P (SP). The cell surface metalloendopeptidase neprilysin (NEP; EC 3.4.24.11) degrades SP in the extracellular fluid, which limits neurokinin 1 receptor (NK 1 R) activation and terminates its proinflammatory actions (2) (3) (4) . G protein receptor kinases (GRKs) phosphorylate agonist-bound NK 1 R to promote interaction with ␤-arrestins, which mediate NK 1 R desensitization and endocytosis and terminate NK 1 R signaling (5) .
In contrast to the termination of GPCR signaling, little is known about GPCR recycling and resensitization, which mediate sustained signaling. The affinity of interaction between GPCRs and ␤-arrestins determines the rate of receptor recycling and resensitization (6) (7) (8) (9) . ''Class B'' GPCRs with multiple GRK phosphorylation sites (e.g., NK 1 R) interact with ␤-arrestin-1 and -2 with high affinity and remain associated with ␤-arrestins in endosomes until the receptor slowly recycles and resensitizes and ␤-arrestins return to the cytosol. ''Class A'' GPCRs with fewer GRK sites (e.g., neurokinin 3 receptor, NK 3 R) interact with low affinity and transiently with ␤-arrestin-2 at the plasma membrane and in endosomes and rapidly recycle and resensitize. Although recycling and resensitization of class B GPCRs, such as the NK 1 R, require endosomal acidification and receptor dephosphorylation (10, 11) , which may promote dissociation of ␤-arrestins, the critical factor that initiates recycling and resensitization is unknown. We report a biological mechanism by which an endopeptidase degrades SP in acidified early endosomes to promote dissociation of SP and ␤-arrestins from the NK 1 R, resulting in rapid NK 1 R recycling and resensitization.
The zinc metalloendopeptidase endothelin-converting enzyme 1 (ECE-1) is related to NEP. In contrast to NEP, which is mostly present at the cell surface (2), the four ECE-1 isoforms (a-d) are expressed at the cell surface and in endosomes (12) (13) (14) . Cell surface ECE-1 cleaves peptides in the extracellular fluid, generating active peptides such as endothelin 1 and inactivating peptides such as bradykinin (15, 16) . The role of ECE-1 in endosomes is unknown. However, ECE-1 can hydrolyze peptides (e.g., SP, bradykinin, neurotensin, angiotensin I), at an acidic pH similar to that of endosomes (17, 18) . Because many peptides traffic to endosomes with their receptors, we hypothesized that ECE-1 degrades peptides in endosomes to disrupt the peptide-receptor-␤-arrestin complex, thereby controlling postendocytic trafficking and signaling of receptors. We examined the role of ECE-1 in trafficking and signaling of the SP NK 1 R. examined the endosomal localization of ECE-1 isoforms. Human ECE-1a-d-GFP were expressed in KNRK cells, which have been extensively used to study NK 1 R trafficking (5, 9-11, 19, 20) . KNRK cells did not express detectable ECE-1 mRNA or protein, assessed by RT-PCR and Western blotting (not shown), and are thus suitable to study the effects of ECE-1 overexpression on NK 1 R trafficking. All isoforms, especially ECE-1b and ECE-1d, colocalized with early endosomal antigen 1 (EEA1) (Fig. 1A) and Rab5a-cyan fluorescent protein (CFP) [supporting information (SI) Fig. 8 ], which mediates NK 1 R trafficking from the plasma membrane to early endosomes (19, 20) . ECE-1a and ECE-1c were also at the plasma membrane, colocalizing with the unstimulated NK 1 R (10). By expressing the constitutively active mutant Rab5aQ79L-CFP, which causes endosomal fusion (21), we confirmed the presence of all ECE-1 isoforms in enlarged endosomes (Fig. 1B) . HEK293 cells, which are often used to study GPCR trafficking, expressed endogenous ECE-1a-d mRNA and ECE-1 protein, detected by RT-PCR and Western blotting (SI Fig. 9 A and B) . Endogenous ECE-1 was localized to EEA1-positive endosomes and enlarged endosomes containing Rab5aQ79L-GFP in HEK cells by using an antibody that crossreacts with ECE-1b and ECE-1d ( Fig. 1 C and D) .
To confirm the presence of ECE-1 isoforms at the cell surface and within the cell, we measured ECE-1 activity by using the substrate McaBK2 (22) . Cell surface ECE-1 activity of nonpermeabilized KNRK-NK 1 R cells was 1/20th that of ECE-1a-transfected cells, confirming expression of active enzyme (Fig. 1E) . Total ECE-1 activity was similar in detergent-permeabilized cells expressing all ECE-1 isoforms, whereas surface ECE-1 activity was greater in cells expressing the ECE-1a and ECE-1c isoforms (Fig. 1F) . The proportion of the total cellular activity that was intracellular (total minus surface) was: ECE-1a, 19 Ϯ 4%; ECE-1b, 75 Ϯ 3%; ECE-1c, 53 Ϯ 3%; and ECE-1d, 96 Ϯ 2%. These results, showing prominent extracellular activity for ECE-1a and ECE-1c, and substantial intracellular activity for all isoforms and especially ECE-1b and ECE-1d, agree with the microscopic localization of ECE-1 isoforms.
SP and NK1R Traffic to Acidified Early Endosomes Containing ECE-1.
We determined whether Alexa-SP traffics to ECE-1-containing endosomes in KNRK-NK 1 R cells expressing ECE-1a-d-GFP. After incubation at 4°C, Alexa-SP was at the plasma membrane, colocalizing with ECE-1a and ECE-1c ( Fig. 2A) . After 30 min at 37°C, Alexa-SP was in endosomes containing all ECE-1 isoforms, notably ECE-1b and ECE-1d (Fig. 2 A) . In HEK-NK 1 R cells, Alexa-SP trafficked from the plasma membrane to colocalize prominently with immunoreactive ECE-1b/d and EEA1 in endosomes (Fig. 2B) . SP also stimulated NK 1 R trafficking to ECE-1-containing endosomes (SI Fig. 10 ). Thus, SP and the NK 1 R traffic to endosomes containing ECE-1 isoforms.
ECE-1 hydrolyzes SP at Gln 6 -Phe 7 and Gly 9 -Leu 10 (17) at pH optimum 5.6-5.8 (18) . To determine whether SP translocates to acidified endosomes, which would favor cleavage by ECE-1, we estimated the pH of endosomes by measuring the emission spectrum of internalized SP tagged with FITC, a fluorophore with pH-dependent emission. FITC-SP (10 min, 37°C) was detected in endosomes in KNRK-NK 1 R cells (not shown and see ref. 10 ). The emission spectrum of internalized FITC-SP was consistent with localization in an acidic compartment of pH 4-7 ( Fig. 2C ), which agrees with an estimated pH 5.3 of Rab5a-positive endosomes (23) .
ECE-1 Degrades SP in Acidified Endosomes but Not at the Cell Surface.
Although ECE-1 may degrade SP at the cell surface and in endosomes, the acidic endosomal environment would facilitate degradation (18) . We examined the rate at which recombinant human (rh) ECE-1 degrades SP at the acidity of extracellular (pH 7.4) and endosomal (pH 5.5) compartments. rhECE-1 degraded SP at pH 5.5 but not pH 7.4 ( Fig. 3A) . SP[1-6] was a major product, indicating Gln 6 -Phe 7 hydrolysis (SI Fig. 11 A) . Although ECE-1 inhibitors also show remarkable pH-dependence (18), the inhibitor SM-19712 (24) prevented rhECE-1 from degrading SP at pH 5.5 ( Fig. 3A and SI Fig. 11B ). rhECE-1 also degraded other NK 1 R agonists at pH 5.5 (degradation in 60 min): SP, 62%; neurokinin A, 40%; hemokinin 1, 25%; endokinin A/B, 62%; endokinin C, 16%; endokinin D, 62. There was no degradation at pH 7.4.
To determine the role of ECE-1 in intracellular degradation of SP, we examined the metabolism of internalized By inducing SP dissociation from the NK 1 R, endosomal acidification may promote SP degradation by ECE-1. We examined the pH-dependence of [ 3 H]SP binding to membranes from HEK-NK 1 R cells. SP binding to the NK 1 R was biphasic, with a 25% reduction from pH 7.5 to 6 and a 75% reduction from pH 6 to 5 (SI Fig. 13 ). At endosomal pH 5.5, 30% of SP was bound to the NK 1 R.
ECE-1 Promotes NK1R Resensitization and Recycling. By degrading SP in acidified endosomes, ECE-1 may promote NK 1 R recycling and resensitization. We examined the effects of ECE-1 overexpression and inhibition on resensitization of SP-induced increases in [Ca 2ϩ ] i . Cells were preincubated with SP (10 min, 37°C) or vehicle, washed, and challenged with 10 nM SP after a 5-to 60-min recovery. Incubation of KNRK-NK 1 R cells with SP caused sustained desensitization of responses to a subsequent challenge; minimal resensitization was detected after 5-30 min, and SP responses were only 27 Ϯ 7% resensitized after 60 min (Fig. 4A) . Overexpression of all ECE-1 isoforms dramatically accelerated resensitization, although the effect was greatest in cells expressing ECE-1c, where resensitization was 100% at 10 min compared with 16 Ϯ 4% resensitization in cells expressing the NK 1 R alone. Responses were completely resensitized in cells expressing all ECE-1 isoforms after 60 min. Conversely, inhibition of endogenous ECE-1 in HEK-NK 1 R cells prevented resensitization. In HEK-NK 1 R cells treated with vehicle (control), responses to SP were fully resensitized after 120 min (100 Ϯ 4% resensitization), whereas in SM-19712-treated cells resensitization was strongly inhibited at this time (38 Ϯ 10% resensitization) (Fig. 4B) . Neither ECE-1 overexpression in KNRK-NK 1 R cells (not shown) nor ECE-1 inhibition in HEK-NK 1 R cells (Fig. 4C) affected the magnitude of responses to an initial challenge with 1 or 10 nM SP, consistent with the observation that ECE-1 does not degrade SP at the pH of extracellular fluid (Fig. 3A) . We similarly examined the effects of ECE-1 inhibition on resensitization of responses to the tachykinin neurokinin B (NKB) in HEK-NK 3 R cells. SM-19712 inhibited resensitization of responses to NKB by Ͼ50% (Fig. 4D ) but did not affect the magnitude of responses to a single challenge with NKB (not shown).
Because recycling mediates NK 1 R resensitization (11, 19, 20) , we examined the effects of an ECE-1 inhibitor on recycling of NK 1 R tagged at the cell surface with HA11 antibody in HEK-NK 1 R cells. SP stimulated endocytosis of NK 1 R within 10 min, which reappeared at the plasma membrane after 4-6 h (Fig. 5A) , indicating normal trafficking of antibody-tagged NK 1 R (10, 25). SM-19712 did not affect endocytosis, but it did cause retention of NK 1 R in endosomes and prevented recycling (Fig. 5A) . Thus, ECE-1 regulates NK 1 R recycling to control resensitization of responses to SP.
ECE-1 Promotes Resensitization of SP-Induced Plasma Extravasation.
SP-induced extravasation of plasma proteins from postcapillary venules rapidly desensitizes and slowly resensitizes, which coincides with endocytosis and recycling of the NK 1 R in endothelial cells (26) . Because endothelial cells also express ECE-1 (27), we hypothesized that ECE-1 controls resensitization of SP-induced plasma extravasation. To examine resensitization of SP-induced plasma extravasation, SP or vehicle was injected intradermally into mice, followed at 30, 60, or 480 min by another injection of SP into the same site; extravasation of Evan's blue into the injection site was determined. As described previously (26) , SP-induced extravasation of Evan's blue desensitized when the interval between two injections of SP was 30 min (62 Ϯ 7% of control) and resensitized after 480 min (104 Ϯ 9% of control) (Fig. 4E) . SM-19712 caused a 30% reduction in resensitization [resensitization at 60 min compared with SP vehicle (100%): SM-19712 vehicle, 69 Ϯ 7%; SM-19712, 47 Ϯ 9%] (Fig. 4F) . Thus, endosomal ECE-1 promotes resensitization of SP-induced inflammation. SM-19712 did not affect the magnitude of extravasation to a single challenge with SP (not shown), suggesting that, unlike NEP (3, 4), endothelial ECE-1 does not degrade extracellular SP to attenuate its proinflammatory actions.
ECE-1 Promotes Translocation of ␤-Arrestins from Endosomes to the
Cytosol. By cleaving SP in endosomes, ECE-1 may generate fragments that are unable to interact with the NK 1 R and thereby promote dissociation of endosomal ␤-arrestins and NK 1 R. SP [1] [2] [3] [4] [5] [6] [7] [8] [9] and SP [7] [8] [9] [10] [11] are the largest N-and C-terminal ECE-1 metabolites (17), but it is not known whether they interact with the NK 1 R to affect association of the receptor with ␤-arrestins. To determine whether these peptides activate the NK 1 R, we assessed their ability to increase [Ca 2ϩ ] i and cause translocation of ␤-arrestin-1-GFP from the cytoplasm to the plasma membrane and endosomes. SP increased [Ca 2ϩ ] i in KNRK-NK 1 R cells (EC 50 of 0.9 Ϯ 0.3 nM; Fig.  6A ). SP [7] [8] [9] [10] [11] was Ͼ3 orders of magnitude less potent than SP, and SP [1] [2] [3] [4] [5] [6] [7] [8] [9] (10 M) did not affect [Ca 2ϩ ] i . In unstimulated KNRK-NK 1 R cells, ␤-arrestin-1-GFP was uniformly cytosolic (Fig. 6B,  arrows) . SP (10 nM) and SP [7] [8] [9] [10] [11] at a 1,000-fold higher concentration (10 M) induced translocation of ␤-arrestin-1-GFP from the cytosol to the plasma membrane within 2 min (Fig. 6B,  arrowheads) . After 10 min with SP, ␤-arrestin-1-GFP was sequestered in endosomes containing NK 1 R (not shown and see ref. 5) , and there was marked depletion of ␤-arrestin-1-GFP from the cytosol. In contrast, after 10 min with SP [7] [8] [9] [10] [11] , ␤-arrestin-1-GFP was mostly cytosolic and in some small vesicles. SP [1] [2] [3] [4] [5] [6] [7] [8] [9] (10 M) did not induce translocation of ␤-arrestin-1-GFP from the cytosol to the plasma membrane or endosomes. Thus, ECE-1 degrades SP to metabolites with greatly diminished capacity (SP [7] [8] [9] [10] [11] ) or inability (SP [1] [2] [3] [4] [5] [6] [7] [8] [9] ) to activate NK 1 R and mobilize ␤-arrestins.
Interaction with ␤-arrestins determines the rates of NK 1 R and NK 3 R recycling and resensitization (6) (7) (8) (9) . To investigate whether ECE-1 regulates this interaction, we examined the effects of ECE-1 overexpression and inhibition on the subcellular localization of ␤-arrestin-1-yellow fluorescent protein (YFP). In KNRK-NK 1 R cells, SP induced translocation of ␤-arrestin-1-YFP from the cytosol into endosomes within 10 min, and ␤-arrestin-1-YFP remained sequestered in endosomes with marked depletion from the cytosol for up to 60 min (Fig. 6 C and D) . Overexpression of ECE-1 did not affect sequestration of ␤-arrestin-1-YFP to endosomes but accelerated its redistribution to the cytosol within 30-60 min (Fig. 6 C and D for ECE-1c; not shown for ECE-1a, 1b, and 1d). In HEK-NK 1 R cells overexpressing ␤-arrestin-1-YFP, SP caused cytosolic depletion of ␤-arrestin-1-YFP and sequestration into endosomes from 10 to 60 min, with return to the cytosol within 3 h (Fig.  5B) . SM-19712 did not affect the sequestration of ␤-arrestin-1-YFP to endosomes but abolished its return to the cytosol after 3 h (Fig.  5B) . Thus, ECE-1 degrades SP in endosomes to promote dissociation of ␤-arrestin-1 from NK 1 R, thereby permitting ␤-arrestin-1 to return to the cytosol and NK 1 R to recycle and resensitize.
Discussion
We report a mechanism by which an endosomal peptidase degrades neuropeptides in endosomes to regulate receptor trafficking and signaling (Fig. 7) . Our results show that the SP-NK 1 R-␤-arrestin complex traffics from the plasma membrane to early endosomes containing ECE-1. ECE-1 degrades SP in acidified endosomes, which promotes the redistribution of ␤-arrestins to the cytosol. The NK 1 R, freed from ␤-arrestins, recycles and resensitizes. Thus, the availability of substrate in endosomes, here controlled by ECE-1, is a critical factor in controlling recycling and resensitization of GPCRs.
All ECE-1 isoforms, but especially ECE-1b and ECE-1d, colocalized with the SP-NK 1 R-␤-arrestin complex in endosomes, although ECE-1c and ECE-1d were mainly at the plasma membrane. These results are consistent with other reports of the presence of ECE-1b in early, recycling, and late endosomes, ECE-1d in recycling endosomes, and ECE-1a and ECE-1c at the plasma membrane (12) (13) (14) . By overexpressing the Rab5aQ79L, which stimulates early endosome fusion (21), we convincingly detected the presence of all ECE-1 isoforms in endosomes. Thus, the subcellular distribution of ECE-1 may be dynamically regulated. ECE-1c, and to a lesser extent ECE-1b and ECE-1d, constitutively internalize by a dynamin-dependent mechanism and recycle (14) . Protein kinase C-mediated phosphorylation regulates the subcellular distribution of ECE-1a (28) . By these mechanisms, GPCRs could control ECE-1 trafficking to endosomes to promote neuropeptide degradation.
ECE-1 degraded and inactivated SP at endosomal but not extracellular acidity, and ECE-1 played a major role in the intracellular degradation of SP in acidified endosomes. Endosomal acidification may facilitate SP hydrolysis by enhancing ECE-1 activity (18) and by inducing SP dissociation from the NK 1 R (10). Some C-terminal SP fragments are agonists, but they do not fully desensitize the NK 1 R, and N-terminal fragments can have antagonistic effects (29, 30) . Thus, ECE-1 would promote SP dissociation from the NK 1 R in endosomes.
Overexpression of ECE-1 induced disassembly of the SP-NK 1 R-␤-arrestin complex in endosomes, causing the redistribution of ␤-arrestins to the cytosol and recycling of the NK 1 R, whereas inhibition of ECE-1 had the opposite effect. Thus, endosomal ECE-1 controls the stability of the SP-NK 1 R-␤-arrestin complex and regulates the postendocytic sorting of ␤-arrestins and the NK 1 R. Whether SP degradation initiates NK 1 R dephosphorylation, which may also promote ␤-arrestin dissociation and NK 1 R recycling (11) , is unknown. The ECE-1 isoform that is mostly responsible for these effects remains to be identified. When overexpressed, all ECE-1 isoforms promoted SP degradation and NK 1 R resensitization. Although ECE-1b and ECE-1d most prominently colocalized with SP in endosomes, overexpression of ECE-1c had the largest effect of SP degradation and NK 1 R resensitization.
Does endosomal ECE-1 degrade other neuropeptides to regulate recycling and resensitization of their receptors? The widespread distribution of ECE-1 (27) , its detection in endosomes (12, 14) , and its broad substrate specificity (17) suggest functions in addition to processing big endothelin. We found that ECE-1 degrades several NK 1 R agonists and regulates resensitization of SP and NKB signaling. ECE-1 also degrades calcitonin gene-related peptide to regulate recycling and resensitization of its receptor (N.W.B., unpublished data). Thus, endosomal ECE-1 can regulate resensitization of class B (NK 1 R) and class A (NK 3 R) receptors. SP, neurokinin A, and calcitonin gene-related peptide mediate neurogenic inflammation and nociception, and we found that an ECE-1 inhibitor delayed resensitization of SP-induced inflammation. Therefore, inhibition of ECE-1 may be therapeutic for neurogenic inflammation and pain, which remains to be examined. ECE-1 also degrades bradykinin and neurotensin (17) and may similarly regulate their receptors. However, ECE-1 does not degrade angiotensin II or regulate resensitization of its receptor (N.W.B., unpublished data). Thus, the process we describe is specific for receptors for ECE-1 substrates.
ECE-1 may also control signaling by endocytosed receptors. ␤-Arrestins are scaffolds for recruitment of mitogen-activated protein kinases to endosomes containing the NK 1 R, and the stability of the interaction between GPCRs and ␤-arrestins affects the activation and function of these kinases (31) . Other endosomal enzymes or transporters may similarly regulate nonpeptide GPCRs. We therefore suggest that agonist availability in endosomes is crucial for controlling trafficking and intracellular signaling of many GPCRs.
Materials and Methods
Reagents, Animals, Antibodies, RT-PCR, Western Blotting, cDNAs, and Cell Lines. See SI Methods.
Localization of ECE-1. Cells were fixed and processed for indirect immunofluorescence (25, 32) by using antibodies to ECE-1 (52-6497, 1:500), EEA1 (1:250), and NK 1 R (FLAG M2, 10 g/ml) (overnight, 4°C). ECE-1, Rab5a, Rab5aQ79L, and ␤-arrestin-1 were detected directly by using GFP, CFP, or YFP.
Endocytosis of Alexa-SP. Cells were incubated with 100 nM Alexa Fluor 594-SP (Invitrogen, Carlsbad, CA) for 60 min at 4°C (8, 20) , washed, incubated for 30 min at 37°C, and fixed.
Recycling of Antibody-Tagged NK1R. Surface NK 1 R was labeled by incubating live KNRK-FLAGNK 1 R or HEK-HA11NK 1 R cells with antibodies to N-terminal NK 1 R epitopes: 30 g/ml anti-FLAG M2 or 1 g/ml anti-HA11 (30-60 min, 4°C or 37°C) (25, 32) . Cells were incubated with 10 nM SP (10-30 min, 37°C), washed, and incubated in SP-free medium (0-6 h, 37°C). Cells Step 1, SP induces NK1R and ␤-arrestin endocytosis.
Step 2, SP-NK 1R-␤-arrestin complex traffics to endosomes.
Step 3, endosome acidification promotes SP dissociation. ECE-1 degrades SP in acidified endosomes disrupting the complex and promoting translocation of ␤-arrestins to the cytosol and NK1R dephosphorylation.
Step 4, NK1R, freed from SP and ␤-arrestins, recycles and resensitizes.
Step 5, NEP degrades SP in extracellular fluid to limit NK 1R signaling.
